Erik Procko

Erik Procko

Auto-generated profile, based on publicly available information

Erik Procko

Department of Biochemistry, University of Illinois, Urbana, USA

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2020 in Science
Verified
Journal Article
Open access
PDF file
KCKui K. Chan
Kui K. Chan
DDDanielle Dorosky
Danielle Dorosky
PSPreeti Sharma
Preeti Sharma
SAShawn A. Abbasi
Shawn A. Abbasi
JDJohn Dye
John Dye
EPErik Procko
Erik Procko
A decoy receptor for SARS-CoV-2: For severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to enter human cells, the spike protein on the surface of the virus must bind to the host receptor protein, angiotensin-converting enzyme 2 (ACE2). A soluble version of the receptor is being explored as a therapeutic. Chan et al. used deep mutagenesis to identify ACE2 mutants that bind more tightly to the spike protein and combined mutations to further increase binding affinity (see the Perspective by DeKosky). A promising variant was engineered to be a stable dimer that has a binding affinity for the spike protein; it is comparable with neutralizing antibodies and neutralized both SARS-CoV-2 and SARS-CoV-1 in a cell-based assay. In addition, the similarity to the natural receptor may limit the possibility for viral escape. Science , this issue p. 1261 ; see also p. 1167

1 June 2007 in Neuron
Verified
Journal Article
Closed access
PLPolina V. Lishko
Polina V. Lishko
EPErik Procko
Erik Procko
XJXiangshu Jin
Xiangshu Jin
CPChristopher B. Phelps
Christopher B. Phelps
RGRachelle Gaudet
Rachelle Gaudet

27 January 2009 in The FASEB Journal
Verified
Journal Article
Closed access
EPErik Procko
Erik Procko
MOMegan L. O'Mara
Megan L. O'Mara
WBW.F. Drew Bennett
W.F. Drew Bennett
DTD. Peter Tieleman
D. Peter Tieleman
RGRachelle Gaudet
Rachelle Gaudet

1 October 2006 in Molecular Cell
Verified
Journal Article
Closed access
EPErik Procko
Erik Procko
ICIan Carter-O'Connell
Ian Carter-O'Connell
SNSze-Ling Ng
Sze-Ling Ng
RGRachelle Gaudet
Rachelle Gaudet

1 June 2014 in Cell
Verified
Journal Article
Closed access
EPErik Procko
Erik Procko
GBGeoffrey Y. Berguig
Geoffrey Y. Berguig
BSBetty W. Shen
Betty W. Shen
YSYifan Song
Yifan Song
SFShani Frayo
Shani Frayo
DBDavid Baker
David Baker

15 October 2001 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
SRSudha Rao
Sudha Rao
EPErik Procko
Erik Procko
MSM. Frances Shannon
M. Frances Shannon
The structure of chromatin and its remodeling following activation are important aspects of the control of inducible gene transcription. The IL-2 gene is induced in a cell specific-manner in T cells following an antigenic stimulus. We show, using a novel real-time PCR assay, that significant chromatin remodeling of the IL-2 proximal promoter region occurred upon stimulation of both the murine EL-4 T cell line and primary CD4+ T cells. Chromatin remodeling appears to be limited to the first 300 bp of the proximal promoter region as measured by micrococcal nuclease and restriction enzyme accessibility. Time course studies indicated that chromatin remodeling was observed at 1.5 h postinduction and was maintained for up to 16 h. The remodeling is reversible upon removal of the stimulus. The region immediately upstream from the transcription start site, however, remains accessible for up to 16 h. Upon restimulation, remodeling occurs much more rapidly, consistent with a more rapid rise in IL-2 mRNA levels. Using a number of pharmacological inhibitors we show that remodeling is dependent on the presence of specific transcription factors, but not on the modification of histones. The development of this novel chromatin accessibility assay based on real-time PCR has allowed rapid, sensitive, and quantitative measurements on the IL-2 gene following cellular activation in both T cell lines and primary cells.